医学
多毛症
抗雄激素
非那雄胺
螺内酯
痤疮
氟他胺
脱发
皮肤病科
睾酮(贴片)
杜他星
激素
内科学
雄激素
抗雄激素
异维甲酸
激素疗法
生理学
癌症
雄激素受体
前列腺癌
前列腺
乳腺癌
心力衰竭
胰岛素抵抗
胰岛素
多囊卵巢
作者
Sarah Azarchi,Amanda Bienenfeld,Kristen Lo Sicco,Shari Marchbein,Jerry Shapiro,Arielle R. Nagler
标识
DOI:10.1016/j.jaad.2018.08.061
摘要
Androgen-mediated cutaneous disorders (AMCDs) in women, including acne, hirsutism, and female pattern hair loss, can be treated with hormone-modulating therapies. In the second article in this Continuing Medical Education series, we discuss the hormone-modulating therapies available to dermatologists for the treatment of AMCDs, including combined oral contraceptives, spironolactone, finasteride, dutasteride, and flutamide. Available hormone-modulating treatments used for each AMCDs are reviewed, along with mechanisms of androgen modulation, safety profile, contraindications, monitoring parameters, and evidence of efficacy. Medications discussed include those that are approved by the US Food and Drug Administration for certain AMCDs and some that are used off-label. Despite the ubiquity of hormone-modulating therapies used for AMCDs, this review highlights the need for more rigorous studies to evaluate these therapies for acne, hirsutism, and female pattern hair loss.
科研通智能强力驱动
Strongly Powered by AbleSci AI